Literature DB >> 22552878

Stem cell therapy in spinal cord injury: in vivo and postmortem tracking of bone marrow mononuclear or mesenchymal stem cells.

Mevci Ozdemir1, Ayhan Attar, Isinsu Kuzu, Murat Ayten, Enver Ozgencil, Melih Bozkurt, Klara Dalva, Duygu Uckan, Emine Kılıc, Tanzer Sancak, Yucel Kanpolat, Meral Beksac.   

Abstract

OBJECTIVE: The aim of this study was to address the question of whether bone marrow-originated mononuclear cells (MNC) or mesenchymal stem cells (MSC) induce neural regeneration when implanted intraspinally.
MATERIALS AND METHODS: The study design included 4 groups of mice: Group 1, non-traumatized control group; Groups 2, 3 and 4 spinal cord traumatized mice with 1 g force Tator clips, which received intralesionally either no cellular implants (Group 2), luciferase (Luc) (+) MNC (Group 3) or MSC (Group 4) obtained from CMV-Luc or beta-actin Luc donor transgenic mice. Following the surgery until decapitation, periodical radioluminescence imaging (RLI) and Basso Mouse Scale (BMS) evaluations was performed to monitor neural activity. Postmortem immunohistochemical techniques were used to analyze the fate of donor type implanted cells.
RESULTS: All mice of Groups 3 and 4 showed various degrees of improvement in the BMS scores, whereas there was no change in Groups 1 and 2. The functional improvement was significantly better in Group 4 compared to Group 3 (18 vs 8, p=0.002). The immunohistochemical staining demonstrated GFP(+)Luc(+) neuronal/glial cells that were also positive with one or more of these markers: nestin, myelin associated glycoprotein, microtubule associated protein or myelin oligodendrocyte specific protein, which is considered as indicator of donor type neuronal regeneration. Frequency of donor type neuronal cells; Luc + signals and median BMS scores were observed 48-64% and 68-72%; 44-80%; 8 and 18 within Groups III and IV respectively. DISCUSSION: MSCs were more effective than MNC in obtaining neuronal recovery. Substantial but incomplete functional improvement was associated with donor type in vivo imaging signals more frequently than the number of neuronal cells expressing donor markers in spinal cord sections in vitro. Our results are in favor of functional recovery arising from both donor MSC and MNCs, contributing to direct neuronal regeneration and additional indirect mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552878     DOI: 10.1007/s12015-012-9376-5

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  40 in total

1.  Stable expression of the alkaline phosphatase marker gene by neural cells in culture and after transplantation into the CNS using cells derived from a transgenic rat.

Authors:  Tahmina Mujtaba; Steve S W Han; Itzhak Fischer; Eric P Sandgren; Mahendra S Rao
Journal:  Exp Neurol       Date:  2002-03       Impact factor: 5.330

2.  Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord.

Authors:  Sufan Wu; Yoshihisa Suzuki; Yoko Ejiri; Toru Noda; Hongliang Bai; Masaaki Kitada; Kazuya Kataoka; Masayoshi Ohta; Hirotomi Chou; Chizuka Ide
Journal:  J Neurosci Res       Date:  2003-05-01       Impact factor: 4.164

3.  Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord.

Authors:  Eva Syková; Pavla Jendelová
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

Review 4.  Promising new sources for pluripotent stem cells.

Authors:  Christian Leeb; Marcin Jurga; Colin McGuckin; Richard Moriggl; Lukas Kenner
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

5.  Generating green fluorescent mice by germline transmission of green fluorescent ES cells.

Authors:  A K Hadjantonakis; M Gertsenstein; M Ikawa; M Okabe; A Nagy
Journal:  Mech Dev       Date:  1998-08       Impact factor: 1.882

6.  Detection of 111In-oxine-labeled bone marrow stromal cells after intravenous or intralesional administration in chronic paraplegic rats.

Authors:  Javier de Haro; Mercedes Zurita; Ladislao Ayllón; Jesús Vaquero
Journal:  Neurosci Lett       Date:  2004-12-15       Impact factor: 3.046

7.  Development of new inbred transgenic strains of rats with LacZ or GFP.

Authors:  Hirokazu Inoue; Ichiro Ohsawa; Takashi Murakami; Atsushi Kimura; Yoji Hakamata; Yuki Sato; Takashi Kaneko; Masafumi Takahashi; Takashi Okada; Keiya Ozawa; Jeremy Francis; Paola Leone; Eiji Kobayashi
Journal:  Biochem Biophys Res Commun       Date:  2005-04-01       Impact factor: 3.575

Review 8.  Adult stem cell transplants for spinal cord injury repair: current state in preclinical research.

Authors:  Joaquim Hernández; Abel Torres-Espín; Xavier Navarro
Journal:  Curr Stem Cell Res Ther       Date:  2011-09       Impact factor: 3.828

9.  Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat.

Authors:  A S Rivlin; C H Tator
Journal:  Surg Neurol       Date:  1978-07

Review 10.  The molecular mechanism of induced pluripotency: a two-stage switch.

Authors:  Wouter Scheper; Sjef Copray
Journal:  Stem Cell Rev Rep       Date:  2009-06-24       Impact factor: 5.739

View more
  16 in total

Review 1.  The Role of Direct Current Electric Field-Guided Stem Cell Migration in Neural Regeneration.

Authors:  Li Yao; Yongchao Li
Journal:  Stem Cell Rev Rep       Date:  2016-06       Impact factor: 5.739

2.  Iron administration before stem cell harvest enables MR imaging tracking after transplantation.

Authors:  Aman Khurana; Fanny Chapelin; Graham Beck; Olga D Lenkov; Jessica Donig; Hossein Nejadnik; Solomon Messing; Nikita Derugin; Ray Chun-Fai Chan; Amitabh Gaur; Barbara Sennino; Donald M McDonald; Paul J Kempen; Grigory A Tikhomirov; Jianghong Rao; Heike E Daldrup-Link
Journal:  Radiology       Date:  2013-07-12       Impact factor: 11.105

3.  Comparison of the efficacy of bone marrow mononuclear cells and bone mesenchymal stem cells in the treatment of osteoarthritis in a sheep model.

Authors:  Fanglong Song; Jilei Tang; Rui Geng; Hansheng Hu; Chunhui Zhu; Weiding Cui; Weimin Fan
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

4.  A Retrospective Analysis of Safety and Efficacy of Wharton's Jelly Stem Cell Administration in Children with Spina Bifida.

Authors:  Dariusz Boruczkowski; Izabela Zdolińska-Malinowska
Journal:  Stem Cell Rev Rep       Date:  2019-10       Impact factor: 5.739

5.  In Vivo Bioluminescence Imaging - A Suitable Method to Track Mesenchymal Stromal Cells in a Skeletal Muscle Trauma.

Authors:  Strohschein K; Radojewski P; Winkler T; Duda G N; Perka C; von Roth P
Journal:  Open Orthop J       Date:  2015-07-31

6.  Synergistic actions of olomoucine and bone morphogenetic protein-4 in axonal repair after acute spinal cord contusion.

Authors:  Liang Chen; Jianjun Li; Liang Wu; Mingliang Yang; Feng Gao; Li Yuan
Journal:  Neural Regen Res       Date:  2014-10-15       Impact factor: 5.135

Review 7.  Repair of injured spinal cord using biomaterial scaffolds and stem cells.

Authors:  Bikesh Shrestha; Katherine Coykendall; Yongchao Li; Alex Moon; Priyanka Priyadarshani; Li Yao
Journal:  Stem Cell Res Ther       Date:  2014-08-01       Impact factor: 6.832

8.  Dynamic Imaging of Marrow-Resident Granulocytes Interacting with Human Mesenchymal Stem Cells upon Systemic Lipopolysaccharide Challenge.

Authors:  Jay T Myers; Deborah S Barkauskas; Alex Y Huang
Journal:  Stem Cells Int       Date:  2013-03-27       Impact factor: 5.443

9.  Combined transplantation of GDAs(BMP) and hr-decorin in spinal cord contusion repair.

Authors:  Liang Wu; Jianjun Li; Liang Chen; Hong Zhang; Li Yuan; Stephen Ja Davies
Journal:  Neural Regen Res       Date:  2013-08-25       Impact factor: 5.135

10.  Synaptic plasticity and sensory-motor improvement following fibrin sealant dorsal root reimplantation and mononuclear cell therapy.

Authors:  Suzana U Benitez; Roberta Barbizan; Aline B Spejo; Rui S Ferreira; Benedito Barraviera; Alfredo M Góes; Alexandre L R de Oliveira
Journal:  Front Neuroanat       Date:  2014-09-09       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.